All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • QLS2319Phase 21 trial

    Qilu Pharmaceutical Co., Ltd. · Cancer Cachexia, Cancer Cachexia Syndrome

  • QLS7305Phase 21 trial

    Qilu Pharmaceutical Co., Ltd. · IgAN - IgA Nephropathy, Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN), C3 Glomerulopathy (C3G)

  • QR-1123Phase 21 trial

    ProQR Therapeutics · Autosomal Dominant Retinitis Pigmentosa, Eye Diseases, Eye Diseases, Hereditary

  • RABI-767Phase 21 trial

    Panafina, Inc. · Acute Pancreatitis

  • RAD10118F-FPIAPhase 21 trial

    Radiopharm Theranostics, Ltd · Brain Metastases From Solid Tumors

  • RatutrelvirPhase 21 trial

    Traws Pharma, Inc. · COVID - 19

  • RavagalimabPhase 21 trial

    AbbVie · Rheumatoid Arthritis

  • RBD1119Phase 21 trial

    Ribocure Pharmaceuticals AB · Stable Coronary Artery Disease

  • RBD4059Phase 21 trial

    Ribocure Pharmaceuticals AB · Stable Coronary Artery Disease CAD

  • RBP-01Phase 21 trial

    ReBio Pharma · Uveal Melanoma

  • RC278Phase 21 trial

    RemeGen Co., Ltd. · Solid Tumors

  • RC288Phase 21 trial

    RemeGen Co., Ltd. · Solid Tumors

  • RCT2100Phase 21 trial

    ReCode Therapeutics · Cystic Fibrosis

  • RCZY690Phase 21 trial

    Rongchang Pharmaceuticals Co., Ltd. · Advanced Malignant Solid Tumors

  • RDX-002Phase 21 trial

    Response Pharmaceuticals · Triglycerides, Weight Gain Trajectory, Cholesterol, Elevated

  • RE03Phase 21 trial

    Reconnect Labs · Posttraumatic Stress Disorder (PTSD), Sleep Disturbances and Insomnia

  • REC-1245Phase 21 trial

    Recursion Pharmaceuticals Inc. · Unresectable, Locally Advanced, Metastatic Cancers

  • REC-4881Phase 21 trial

    Recursion Pharmaceuticals Inc. · Familial Adenomatous Polyposis

  • REC-7735Phase 21 trial

    Recursion Pharmaceuticals Inc. · Solid Tumors

  • REC-994Phase 21 trial

    Recursion Pharmaceuticals Inc. · Cerebral Cavernous Malformation

  • RedasemtideRedasemtide trifluoroacetate, S-005151Phase 21 trial

    Shionogi · Acute Ischemic Stroke

  • Helsinn Healthcare SA · Nausea and Vomiting Chemotherapy-Induced, Nausea Post Chemotherapy

  • REGN13089-M404-M2980Phase 21 trial

    Regeneron · Advanced Solid Tumors

  • REGN13335Phase 21 trial

    Regeneron · Pulmonary Arterial Hypertension (PAH)

  • REGN15505Phase 21 trial

    Regeneron · Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)

  • REGN17372Phase 21 trial

    Regeneron · Relapsed Refractory Multiple Myeloma (RRMM)

  • REGN21353Phase 21 trial

    Regeneron · Metastatic Castration-Resistant Prostate Cancer, mCRPC

  • REGN22530Phase 21 trial

    Regeneron · Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT)

  • REGN5093davutamigPhase 21 trial

    Regeneron · NSCLC

  • REGN5381Phase 21 trial

    Regeneron · Heart Failure

  • REGN5668ubletamigPhase 21 trial

    Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

  • REGN7945Phase 21 trial

    Regeneron · Relapsed/Refractory Multiple Myeloma

  • REGN7999Phase 21 trial

    Regeneron · Non-Transfusion Dependent Beta-Thalassemia (NTDT)

  • REGN9220Phase 21 trial

    Regeneron · Diffuse Large B-Cell Lymphoma (DLBCL)

  • REGV131Phase 21 trial

    Regeneron · Hemophilia B

  • Relmacabtagene AutoleucelJWCAR029Phase 21 trial

    Shanghai Ming Ju Biotechnology Co., Ltd. · Lymphoma, Large B-Cell, Diffuse, Follicular Lymphoma Grade 3B, High-grade B-cell Lymphoma

  • REM-422Phase 21 trial

    Remix Therapeutics · Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma

  • RemzistotugPhase 21 trial

    GSK · Neoplasms, Head and Neck

  • RenadirsenDS-5141bPhase 21 trial

    Daiichi Sankyo · Duchenne Muscular Dystrophy

  • RESP302Phase 21 trial

    Thirty Respiratory Limited · Non-Cystic Fibrosis Bronchiectasis

  • RESP303Phase 21 trial

    Thirty Respiratory Limited · Non-Cystic Fibrosis Bronchiectasis

  • RESP30TBPhase 21 trial

    Thirty Respiratory Limited · Pulmonary Tuberculoses

  • RG002Phase 21 trial

    RinuaGene Biotechnology Co., Ltd. · Human Papillomavirus Associated Intraepithelial Neoplasia, Cervical Intraepithelial Neoplasia Grade 2/3, Human Papillomavirus Type 16 Infection

  • RG002C0106Phase 21 trial

    Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. · IgA Nephropathy (IgAN)

  • RGH-202Phase 21 trial

    Gedeon Richter Plc. · Social Anxiety Disorder

  • RGT001-075Phase 21 trial

    Regor Pharmaceuticals Inc. · Obesity or Overweight

  • RHH646Phase 21 trial

    Novartis · Osteoarthritis, Knee

  • RibaxamasePhase 21 trial

    Theriva Biologics, Inc. · Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant, Prevention of CDI in Adult Patients Being Treated With IV Beta-lactam Antibiotics

  • RIG-101Phase 21 trial

    RIGImmune Inc. · Healthy Adult Participants, Asthma Exacerbation, Safety and Efficacy

  • RiMO-301Phase 21 trial

    Coordination Pharmaceuticals, Inc. · Head Neck Cancer, Intratumoral Injection

NewerPage 66 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.